We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BIIB market cap is 19.43B. The company's latest EPS is USD 7.9681 and P/E is 16.75.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.53B | 2.39B | 2.29B | 2.46B | 2.47B |
| Operating Income | 44.8M | 358.9M | 558.5M | 695.3M | 489.6M |
| Net Income | -68.1M | 249.7M | 393.4M | 583.6M | 388.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.38B | 13.44B | 10.98B | 10.17B | 9.84B |
| Operating Income | 7.03B | 4.37B | 3.04B | 2.76B | 1.61B |
| Net Income | 5.89B | 4B | 1.81B | 3.05B | 1.16B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.19B | 26.84B | 26.57B | 26.8B | 28.31B |
| Total Liabilities | 13.71B | 12.05B | 11.35B | 10.92B | 11.95B |
| Total Equity | 14.48B | 14.8B | 15.21B | 15.89B | 16.36B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.23B | 24.62B | 23.88B | 24.55B | 26.84B |
| Total Liabilities | 13.9B | 13.93B | 12.92B | 11.17B | 12.05B |
| Total Equity | 13.34B | 10.69B | 10.96B | 13.39B | 14.8B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.53B | 1.55B | 553.2M | 1.18B | 2.11B |
| Investing | -3.45B | -4.1B | -66M | 400.5M | -780.6M |
| Financing | 795.4M | 149.3M | -439.6M | -684.8M | -691.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.08B | 4.23B | 3.64B | 1.38B | 1.55B |
| Investing | 470.5M | -608.6M | -563.7M | 1.58B | -4.1B |
| Financing | -5.86B | -5.27B | -2.09B | -1.75B | 149.3M |
| Market Cap | 19.43B |
| Price to Earnings Ratio | 16.75 |
| Price to Sales Ratio | 1.98 |
| Price to Cash Ratio | 18.52 |
| Price to Book Ratio | 1.31 |
| Dividend Yield | - |
| Shares Outstanding | 145.72M |
| Average Volume (1 week) | 1.89M |
| Average Volume (1 Month) | 1.42M |
| 52 Week Change | -43.40% |
| 52 Week High | 238.00 |
| 52 Week Low | 128.511 |
| Spread (Intraday) | 1.18 (0.89%) |
| Company Name | Biogen Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.biogen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
